AZN vs PLUS · P/E 28, $288.38B cap vs P/E 17, rev $2.07B
AstraZeneca PLC (AZN) versus ePlus inc (PLUS) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
ePlus inc (PLUS) is a software - application company listed on NASDAQ.
AZN does not have a complete income-statement cache yet.
Latest reported PLUS revenue for 2025-03-31 was $2.07B. Net income was $108.0M. Revenue was down 7.0% from 2024-03-31 to 2025-03-31. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
Not investment advice. Open the AZN and PLUS stock pages for the full models.
Not investment advice.